Developing an evaluated patient-mediated intervention for monitoring amiodarone therapy

Amiodarone is used to prevent atrial and ventricular arrhythmias
in high-risk patients, such as after a myocardial infarction (MI)
and in congestive cardiac failure. Its use has increased since the mid-1990s
and, in 2001, around one million prescriptions were dispensed in primary care in England.